These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6869869)

  • 21. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.
    Andreasen PB; Hutters L
    Acta Med Scand Suppl; 1979; 624():99-105. PubMed ID: 284720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Both phenolic and acyl glucuronidation pathways of diflunisal are impaired in liver cirrhosis.
    Macdonald JI; Wallace SM; Mahachai V; Verbeeck RK
    Eur J Clin Pharmacol; 1992; 42(5):471-4. PubMed ID: 1606992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temazepam clearance unaltered in cirrhosis.
    Ochs HR; Greenblatt DJ; Verburg-Ochs B; Matlis R
    Am J Gastroenterol; 1986 Jan; 81(1):80-4. PubMed ID: 2867675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline disposition in patients with hepatic cirrhosis.
    Piafsky KM; Sitar DS; Rangno RE; Ogilvie RI
    N Engl J Med; 1977 Jun; 296(26):1495-7. PubMed ID: 865528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sufentanil pharmacokinetics in patients with cirrhosis.
    Chauvin M; Ferrier C; Haberer JP; Spielvogel C; Lebrault C; Levron JC; Duvaldestin P
    Anesth Analg; 1989 Jan; 68(1):1-4. PubMed ID: 2521279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol.
    Kessler KM; Humphries WC; Black M; Spann JF
    Am Heart J; 1978 Nov; 96(5):627-35. PubMed ID: 263396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cimetidine clearance and bioavailability in hepatic cirrhosis.
    Sonne J; Poulsen HE; Døssing M; Larsen NE; Andreasen PB
    Clin Pharmacol Ther; 1981 Feb; 29(2):191-7. PubMed ID: 7460483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
    Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
    Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancuronium pharmacokinetics in patients with liver cirrhosis.
    Duvaldestin P; Agoston S; Henzel D; Kersten UW; Desmonts JM
    Br J Anaesth; 1978 Nov; 50(11):1131-6. PubMed ID: 718783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and protein binding of propofol in patients with cirrhosis.
    Servin F; Desmonts JM; Haberer JP; Cockshott ID; Plummer GF; Farinotti R
    Anesthesiology; 1988 Dec; 69(6):887-91. PubMed ID: 3264120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopental pharmacokinetics under conditions of long-term infusion.
    Turcant A; Delhumeau A; Premel-Cabic A; Granry JC; Cottineau C; Six P; Allain P
    Anesthesiology; 1985 Jul; 63(1):50-4. PubMed ID: 4014770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis.
    Hu OY; Tang HS; Chang CL
    J Clin Pharmacol; 1995 Mar; 35(3):250-8. PubMed ID: 7608313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose thiopental pharmacokinetics in brain-injured children and neonates.
    Demarquez JL; Galperine R; Billeaud C; Brachet-Liermain A
    Dev Pharmacol Ther; 1987; 10(4):292-300. PubMed ID: 3608752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of cimetidine in advanced cirrhosis.
    Grahnén A; Jameson S; Lööf L; Tyllström J; Lindström B
    Eur J Clin Pharmacol; 1984; 26(3):347-55. PubMed ID: 6734697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.